Martin Madaus

Martin Madaus

Director Ejecutivo en AZENTA, INC. .

Fortuna: 3 M $ al 30/09/2026

66 años
Health Technology
Commercial Services
Health Services

Perfil

Martin D.
Madaus
is President, Chief Executive Officer & Director at Azenta, Inc. since 2026.
He is Chairman of Repligen Corp.
starting in 2026.
He serves as Executive Chairman at Emulate, Inc. since 2020.
He holds director positions at Candela Corp., Massachusetts High Technology Council, Inc., Unchained Labs LLC since 2021, Ultivue, Inc., Candela Medical, Inc. since 2018, Syntis Bio, Inc., Haemonetics Corp.
starting in 2026, and is Senior Operating Executive at The Carlyle Group Inc. since 2019.
Former roles include Chairman, President & Chief Executive Officer at EMD Millipore Corp.
in 2010; Chairman & Chief Executive Officer at Ortho-Clinical Diagnostics, Inc. from 2014 to 2019; President & Chief Executive Officer at Roche Diagnostics Corp.
from 2000 to 2004; Chairman, President & Chief Executive Officer at Millipore SA from 2005 to 2010; Independent Director at Mettler-Toledo International, Inc. from 2011 to 2015; Independent Director at Covidien Unlimited Co. from 2011 to 2014; Independent Director at Standard BioTools, Inc. from 2022 to 2024; Independent Director at Hologic, Inc. from 2024 to 2026; Director at Quanterix Corp.
from 2010 to 2025; Chief Operations Officer at Sherlock Biosciences, Inc. from 2020 to 2021; Vice President-Business Development at Roche Molecular Systems, Inc.; Director at Pharmaceutical Product Development LLC, New England Healthcare Institute, Massachusetts Technology Collaborative, Predictive Biosciences, Inc., Young Men's Christian Association of Greater Boston, Inc., and Analytical Life Science & Diagnostics Association.
Education includes doctorates from Ludwig-Maximilians-Universität München in 1985 and The University of Veterinary Medicine Hanover.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
14/05/2026 8.392 ( 0,01 % ) 2 M $ 30/09/2026
22/09/2026 42.602 ( 0,1 % ) 1 M $ 30/09/2026
24/07/2026 2.538 ( 0,01 % ) 267 251 $ 30/09/2026

Cargos activos de Martin Madaus

EmpresasCargoInicio
CANDELA MEDICAL, INC. Director/Miembro de la Junta 01/05/2018
REPLIGEN CORPORATION Presidente 13/03/2026
AZENTA, INC. Director Ejecutivo 22/08/2026
HAEMONETICS CORPORATION Director/Miembro de la Junta 24/07/2026
THE CARLYLE GROUP INC. Corporate Officer/Principal 01/01/2019
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director/Miembro de la Junta 01/07/2021
Director/Miembro de la Junta -
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ -
░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░

Antiguos cargos conocidos de Martin Madaus.

EmpresasCargoFin
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Martin Madaus.

Formación de Martin Madaus.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

65

Relaciones de 1er grado

31

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas31

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Technology Services

Health Technology

Commercial Services

Health Services

Commercial Services

Health Services

Commercial Services

Electronic Technology

Finance

Analytical Life Science & Diagnostics Association

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology